India`s largest drugmaker, Sun Pharmaceutical Industries Ltd, posted a 59 percent plunge in second-quarter profit on Tuesday, but beat estimates.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

Profit came in at 9.12 billion rupees ($139.48 million) in the quarter ended Sept. 30, compared with 22.35 billion rupees a year ago, the company said. 

Analysts on average had expected a profit of 8.27 billion rupees, according to Thomson Reuters data.